Avalon GloboCare Appoints Dr. Cavo to Advisory Board
Company Announcements

Avalon GloboCare Appoints Dr. Cavo to Advisory Board

Avalon GloboCare ( (ALBT) ) just unveiled an announcement.

Avalon GloboCare has appointed Dr. Charles Cavo to its Scientific and Clinical Advisory Board to enhance the development and marketing of KetoAir™, a breathalyzer for ketogenic health. Dr. Cavo, an expert in obesity medicine, brings significant experience to Avalon, aiming to leverage KetoAir™ as a tool for real-time metabolic insights to aid in weight management and chronic conditions like diabetes. This innovative device offers a non-invasive way to monitor ketosis, potentially transforming how individuals approach ketogenic diets and health strategies.

For detailed information about ALBT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAvalon appoints Cavto to Scientific Advisory Board
Sheryl ShethUpcoming Stock Splits This Week (October 28 to November 1) – Stay Invested
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App